MAM
Nadir Godrej felicitated with ‘Exemplary Industrialist of the Nation’ awards
Mumbai: Sashakt Bharat 2022 on Friday awarded Godrej Industries chairman and managing director Nadir Godrej with the ‘Exemplary Industrialist of the Nation’ award for his outstanding contributions to the Indian industry and his role in bringing pride to the nation.
Nadir was named as the winner of this award in recognition of his achievements as a conscientious, well-respected, and prosperous industrialist.
He was awarded at the coffee table book launch ceremony at the Sashakt Bharat 2022, an initiative by Abhyudaya Vatsyalam to honour the glorious story of India’s development and the stellar personalities associated with it.
On winning this award, Nadir said, “It is indeed an honour to receive this prestigious award. I believe we at Godrej are privileged to be part of our country’s growth journey by being able to serve our nation through our innovative products and solutions. I wish to thank the esteemed board of guest editors for this recognition.”
The launch ceremony witnessed the presence of Aditya Birla Centre community initiatives and rural development chairperson Rajashree Birla as the chief guest. HDFC group chairman Deepak Parekh was also the guest of honour, along with Nadir Godrej.
The board of guest editors for this year’s list includes Shailesh Haribhakti and Associates chairman Shailesh Haribhakti, SEBI, LIC former chairman G. N. Bajpai, IndAsia Fund Advisors chairman Pradip Shah, EdelGive Foundation executive chairperson Vidya Shah, HDFC Mutual Fund MD & CEO Navneet Munot, SUD Life Insurance MD & CEO Abhay Tewari, Oswal Industries director Ravi Doshi and Universal Sompo General Insurance MD & CEO Sharad Mathur, among others.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
